427 related articles for article (PubMed ID: 34516251)
21. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.
Wareham DW; Bean DC
Ann Clin Microbiol Antimicrob; 2006 Apr; 5():10. PubMed ID: 16630352
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Piperacillin-Tazobactam-Meropenem Synergy against Serine Carbapenemase-Producing
Lawandi A; Leite GC; Cheng MP; Lefebvre B; Longtin J; Lee TC
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468471
[TBL] [Abstract][Full Text] [Related]
24. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
Beganovic M; Daffinee KE; Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
[No Abstract] [Full Text] [Related]
25. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
Barth N; Ribeiro VB; Zavascki AP
Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, bla
Firmo EF; Oliveira Júnior JB; Scavuzzi AML; Alves LC; Brayner FA; Veras DL; Lopes ACS
J Glob Antimicrob Resist; 2020 Sep; 22():511-514. PubMed ID: 32344124
[TBL] [Abstract][Full Text] [Related]
27. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
[TBL] [Abstract][Full Text] [Related]
28. Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
Michail G; Labrou M; Pitiriga V; Manousaka S; Sakellaridis N; Tsakris A; Pournaras S
Antimicrob Agents Chemother; 2013 Dec; 57(12):6028-33. PubMed ID: 24060874
[TBL] [Abstract][Full Text] [Related]
29. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Zhang R; Cai JC; Zhou HW; Nasu M; Chen GX
J Med Microbiol; 2011 Dec; 60(Pt 12):1813-1819. PubMed ID: 21835972
[TBL] [Abstract][Full Text] [Related]
30. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
31. Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
Brennan-Krohn T; Truelson KA; Smith KP; Kirby JE
J Antimicrob Chemother; 2017 Oct; 72(10):2775-2781. PubMed ID: 29091221
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
Erdem F; Abulaila A; Aktas Z; Oncul O
Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
[TBL] [Abstract][Full Text] [Related]
33. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
[TBL] [Abstract][Full Text] [Related]
34. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
[TBL] [Abstract][Full Text] [Related]
35. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
Abbas HA; Kadry AA; Shaker GH; Goda RM
Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
[TBL] [Abstract][Full Text] [Related]
36. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
[TBL] [Abstract][Full Text] [Related]
37. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data.
Zhao C; Wistrand-Yuen P; Lagerbäck P; Tängdén T; Nielsen EI; Friberg LE
Int J Antimicrob Agents; 2020 Jun; 55(6):105941. PubMed ID: 32171741
[TBL] [Abstract][Full Text] [Related]
38. Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model.
Cai Y; Lim TP; Teo JQ; Sasikala S; Chan EC; Hong YJ; Lee W; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795375
[TBL] [Abstract][Full Text] [Related]
39. Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant
Wences M; Wolf ER; Li C; Singh N; Bah N; Tan X; Huang Y; Bulman ZP
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884213
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
